Upstream Bio, Inc. (UPB) has received a new Buy rating, initiated by TD Cowen analyst, Yaron Werber. Yaron Werber has given his Buy rating due ...

Yasmeen Rahimi, an analyst from Piper Sandler, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Yasmeen Rahimi has given her Buy ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market.

Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported their initial public offerings.Shares in device maker CeriBell Inc.

Upstream Bio (UPB) shares rallied 32% Friday following the asthma drug developer’s $255M upsized initial public offering. Read more here.

The global upstream bioprocessing equipment market was valued at approximately US$ 7.75 billion in 2022 and is expected to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company ...

Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, visits the Nasdaq ...

Question: Auwe! Saturday was a shocking day at the Ala Wai Canal. Huge amounts of tree debris and garbage were floating ...

Q3 2024 Earnings Conference Call November 1, 2024 11:00 AM ETCompany ParticipantsPeter Shaw - VP, IRBrad Corson - ...

This page features the latest news about the Upstream Bio stock. OrbiMed Advisors LLC purchases $14 million in Upstream Bio shares OrbiMed Advisors LLC, a prominent shareholder in Upstream Bio ...